Patents/Assignees

ADS Therapeutics LLC

6 patents in portfolio

US12491183utility2025
Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization
0 cites
US12485177utility2025
Topical Ophthalmological Compositions
0 cites
US12214049utility2025
Anti-angiogenic Antibody-drug Conjugates
0 cites
US12156873utility2024
Composition for Treating Ocular Hyperemia and a Method for Treating Ocular Hyperemia with the Same
0 cites
US12070501utility2024
Topical Ophthalmological Compositions
0 cites
US11911379utility2024
Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization
0 cites